Symptomatic severity of PRIME-MD diagnosed episodes of panic and generalized anxiety disorder in primary care
- PMID: 16050857
- PMCID: PMC1490149
- DOI: 10.1111/j.1525-1497.2005.0120.x
Symptomatic severity of PRIME-MD diagnosed episodes of panic and generalized anxiety disorder in primary care
Abstract
Background: Panic disorder (PD) and generalized anxiety disorder (GAD) are often unrecognized by primary care physicians (PCPs). The Primary Care Evaluation of Mental Disorders (PRIME-MD) has been used as a case-finding instrument for depression. Yet, little is known on its usefulness as a case-finding tool for anxiety disorders within the context of a clinical trial.
Objective: To examine the: (1) completion rate of the PRIME-MD by patients approached to enroll in a treatment study for PD and GAD; (2) distribution of anxiety diagnoses generated; (3) severity of PD and GAD episodes thus identified; and (4) level of PCPs' agreement with these diagnoses.
Design: Cross-sectional interview.
Patients: Individuals aged 18 to 64 who presented for care at 4 primary care practices.
Measurements: The PRIME-MD, Structured Interview Guide for the Hamilton Anxiety Rating Scale (SIGH-A), and the Panic Disorder Severity Scale (PDSS).
Results: Of the 6,700 patients who completed the PRIME-MD Patient Questionnaire (PQ), 2,926 (44%) screened positive for an anxiety disorder, and 1,216 (42%) met preliminary study eligibility and consented to the PRIME-MD Anxiety Module. Of these, 619 (51%) had either GAD (308), PD (94), or both (217) disorders. Later, 329 completed a telephone interview. Of these, 59% with GAD and 68% with PD reported moderate or greater levels of anxiety symptoms on the SIGH-A and PDSS, respectively, and PCPs agreed with the PRIME-MD diagnosis for 98% of these patients.
Conclusions: The PRIME-MD can efficiently screen patients for PD and GAD. Although patients thus identified endorse a wide range of anxiety symptoms, PCPs often agree with the diagnosis.
Figures


Similar articles
-
Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease.Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):498-504. doi: 10.1161/CIRCOUTCOMES.111.000049. Epub 2013 Jun 11. Circ Cardiovasc Qual Outcomes. 2013. PMID: 23759474 Clinical Trial.
-
Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety.J Psychosom Res. 2008 Jun;64(6):605-12. doi: 10.1016/j.jpsychores.2008.02.019. Epub 2008 Apr 28. J Psychosom Res. 2008. PMID: 18501261
-
Pain adversely affects outcomes to a collaborative care intervention for anxiety in primary care.J Gen Intern Med. 2013 Jan;28(1):58-66. doi: 10.1007/s11606-012-2186-2. Epub 2012 Aug 10. J Gen Intern Med. 2013. PMID: 22878857 Free PMC article. Clinical Trial.
-
Generalized anxiety disorder and its comorbidities: disputes at the boundaries.Acta Psychiatr Scand Suppl. 1998;393:12-22. doi: 10.1111/j.1600-0447.1998.tb05961.x. Acta Psychiatr Scand Suppl. 1998. PMID: 9777042 Review.
-
Diagnosis and management of generalized anxiety disorder and panic disorder in adults.Am Fam Physician. 2015 May 1;91(9):617-24. Am Fam Physician. 2015. PMID: 25955736 Review.
Cited by
-
Generalized anxiety disorder in older medical patients: diagnostic recognition, mental health management and service utilization.J Clin Psychol Med Settings. 2009 Jun;16(2):178-85. doi: 10.1007/s10880-008-9144-5. Epub 2009 Jan 18. J Clin Psychol Med Settings. 2009. PMID: 19152056 Free PMC article. Clinical Trial.
-
Initial severity and antidepressant efficacy for anxiety disorders, obsessive-compulsive disorder, and posttraumatic stress disorder: An individual patient data meta-analysis.Depress Anxiety. 2018 Jun;35(6):515-522. doi: 10.1002/da.22737. Epub 2018 Apr 16. Depress Anxiety. 2018. PMID: 29659102 Free PMC article.
-
Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.Expert Rev Neurother. 2009 Aug;9(8):1147-58. doi: 10.1586/ern.09.37. Expert Rev Neurother. 2009. PMID: 19673604 Free PMC article. Review.
-
Protocol for a randomised controlled trial investigating the effectiveness of an online e health application for the prevention of Generalised Anxiety Disorder.BMC Psychiatry. 2010 Mar 21;10:25. doi: 10.1186/1471-244X-10-25. BMC Psychiatry. 2010. PMID: 20302678 Free PMC article. Clinical Trial.
-
Recognizing and managing anxiety disorders in primary health care in Turkey.BMC Fam Pract. 2010 Apr 28;11:30. doi: 10.1186/1471-2296-11-30. BMC Fam Pract. 2010. PMID: 20426828 Free PMC article.
References
-
- Stein MB, Barrett-Connor E. Quality of life in older adults receiving medications for anxiety, depression, or insomnia. findings from a community-based study Am J Geriatric Psychiatry. 2002;10:568–574. - PubMed
-
- Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Mortality and quality of life 12 months after myocardial infarction. effects of depression and anxiety Psychosomatic Med. 2001;63:221–230. - PubMed
-
- Cass AR, Volk RJ, Nease DE., Jr Health-related quality of life in primary care patients with recognized and unrecognized mood and anxiety disorders. Int J Psychiatry Med. 1999;29:293–309. - PubMed
-
- Greenberg PE, Sisitsky T, Kessler RC, et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry. 1999;60:427–435. - PubMed
-
- Regier DA, Boyd JH, Burke JD, Jr, et al. One-month prevalence of mental disorders in the United States. Based on five epidemiologic catchment area sites. Arch Gen Psychiatry. 1988;45:977–986. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous